NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma.

Saved in:
Bibliographic Details
Title: NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma.
Authors: Zhai Z; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Vaddi PK; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Samson JM; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Takegami T; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Fujita M; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO 80045, USA.; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2020 Dec 30; Vol. 14 (1). Date of Electronic Publication: 2020 Dec 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33396632
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhai+Z%22">Zhai Z</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Vaddi+PK%22">Vaddi PK</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Samson+JM%22">Samson JM</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Takegami+T%22">Takegami T</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.<br /><searchLink fieldCode="AU" term="%22Fujita+M%22">Fujita M</searchLink>; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO 80045, USA.; Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2020 Dec 30; Vol. 14 (1). <i>Date of Electronic Publication: </i>2020 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33396632
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph14010023
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhai Z
      – PersonEntity:
          Name:
            NameFull: Vaddi PK
      – PersonEntity:
          Name:
            NameFull: Samson JM
      – PersonEntity:
          Name:
            NameFull: Takegami T
      – PersonEntity:
          Name:
            NameFull: Fujita M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 12
              Text: 2020 Dec 30
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 1424-8247
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Pharmaceuticals (Basel, Switzerland)
              Type: main
ResultId 1